APVO: Aptevo Therapeutics, Inc. Company Short-Term Debt
The market capitalization trend for Aptevo Therapeutics (APVO) on the GURU.Markets platform, which currently stands at 0.00, is based on the creation of specific antibodies to combat tumors, where patent barriers guarantee a stable income. Aptevo Therapeutics (APVO) relies on the ADAPT platform to develop bifunctional drugs, allowing for flexible management of therapy costs. Business efficiency is enhanced through the implementation of automated clinical data analysis systems and robotic screening.
Metric breakdowns and analytics for Aptevo Therapeutics, Inc. (APVO)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Aptevo Therapeutics|APVO - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Aptevo|APVO - Company Total Debt|Debt to Book Capitalization Ratio Aptevo Therapeutics Inc.|APVO - Company Long-Term Liabilities|Company Current Liabilities Aptevo Therapeutics|Quick Liquidity aptevotherapeutics.com
- net income and valuation multiples indicators:
Initial company analysis:APVO - aptevotherapeutics.com
This indicator aggregates obligations with maturities of up to one year, measuring the issuer's ability to service its loan portfolio without compromising operational activities. For Aptevo Therapeutics (APVO), which focuses on costly R&D research in immuno-oncology, analyzing current short-term liabilities allows for an assessment of liquidity shortage risks when funding early-phase clinical trials and determining the sustainability of the business model.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|Upstream Bio Corp - Company Short-Term Debts|ZBIO - Company Short-Term Debts|Immunome, Inc. (IMNM) - Company Short-Term Debt|Current Liabilities GOSS (gossamerbio.com)|Company Current Liabilities KALV|SEPN (Septerna, Inc.) - Amount of Current Liabilities|Company Short-Term Debts PVLA|SVRA - Short-Term Debt|Rigel Pharmaceuticals - Company Current Liabilities|anaptysbio.com - Company Short-Term Debt|ATXS - Company Short-Term Debt|Short-Term Debt enGene Holdings Inc|RAPT (RAPT Therapeutics) - Company Current Liabilities|Aerovate Therapeutics - Company Short-Term Loans and Borrowings|Company Current Liabilities ACRS|KYTX (kyvernatx.com) - Amount of Current Liabilities|Company Short-Term Debts TLSA|CABA (Cabaletta Bio Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debts VTYX (Ventyx Bio)|Theratechnologies, Inc (THTX) - Short-Term Debt|AVTX - Company Short-Term Debt|Company Short-Term Loans and Borrowings ELDN (eledon.com)|AGEN: Company Short-Term Debts|Climb Bio Inc. (CLYM) - Company Short-Term Debts|Company Short-Term Debt Zura Bio|aTyr Pharmaceuticals - Current Liabilities|Company Short-Term Debts ADAG|IMA - Short-Term Debt|Shattuck Labs - Company Current Liabilities|Company Short-Term Debts Equillium Inc EQ|CNTB: Company Current Liabilities|Immunic, Inc. - Amount of Current Liabilities|ATRA: Company Short-Term Debts|IFRX - Short-Term Debt Volume|XFOR (X4 Pharmaceuticals, Inc.) - Company Short-Term Debts|Company Current Liabilities Adicet (ACET)|Company Short-Term Debt Celularity Inc. (CELU)|Short-Term Debt Volume INmune Bio Corporation|Company Short-Term Debts BRNS (Barinthus Biotherapeutics)|Company Short-Term Debts kezarlifesciences.com KZR|SABS - Company Short-Term Debt|Current Liabilities AKTX|ENLV (enlivex.com) - Company Current Liabilities|QTTB (Q32 Bio) - Company Short-Term Debt|Company Short-Term Debt GeoVax Labs, Inc.|Short-Term Debt edesabiotech.com EDSA|Company Short-Term Debt iBio (IBIO)|CARM: Current Liabilities|Company Short-Term Debts XTLB (XTL Biopharmaceuticals, Ltd.)|Company Short-Term Loans and Borrowings BOLT|HCW Biologics Inc - Company Short-Term Debts|AIM - Company Short-Term Debts|aditxt.com (ADTX) - Company Short-Term Debt|GRI Bio Inc - Company Short-Term Loans and Borrowings|Company Short-Term Debt XORTX|Company Current Liabilities Vyome Therapeutics (HIND)|Company Short-Term Debts REVB|Company Short-Term Debts indaptusrx.com (INDP)|Scinai Immunotherapeutics Ltd. - Company Current Liabilities|Company Short-Term Loans and Borrowings CALI|Affimed Therapeutics - Company Short-Term Debts|Short-Term Debt Volume Allakos Inc. ALLK|hookipapharma.com (HOOK) - Company Short-Term Debt|Company Current Liabilities IGM Biosciences|Company Short-Term Debt iTeos Therapeutics, Inc.|Company Current Liabilities Ocean Biomedical Inc (OCEA)|Company Current Liabilities TCBP (TC BioPharm (Holdings) PLC)|Company Short-Term Debts Third Harmonic Bio Inc (THRD)